What do systematic reviews say?

Interleukin‐2 RA induction vs monoclonal antibody induction

Interleukin‐2 RA induction showed no clear difference in post‐transplantation lymphoproliferative disorder Number of… compared with monoclonal antibody induction (low certainty).

• Immunosuppressive T‐cell antibody induction for heart transplant recipients 2013 · Cochrane Headline outcomes only
  RR 0.31 [0.01, 7.38]
  2 studies · 159 participants
  Low

Monoclonal antibody vs polyclonal antibody

Monoclonal antibody showed no clear difference in post‐transplantation lymphoproliferative disorder Number of… compared with polyclonal antibody (low certainty).

• Immunosuppressive T‐cell antibody induction for heart transplant recipients 2013 · Cochrane Headline outcomes only
  RR 3.84 [0.45, 32.96]
  4 studies · 157 participants
  Low

Interleukin‐2 RA vs polyclonal antibody induction

• Immunosuppressive T‐cell antibody induction for heart transplant recipients 2013 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 185 participants
  Low

Interleukin‐2 RA vs no induction

Interleukin‐2 RA showed no clear difference in post‐transplantation lymphoproliferative disorder Number of… compared with no induction (low certainty).

• Immunosuppressive T‐cell antibody induction for heart transplant recipients 2013 · Cochrane Headline outcomes only
  RR 0.61 [0.08, 4.92]
  4 studies · 576 participants
  Low

Intervention not reported

The intervention showed no clear difference in post‐transplantation lymphoproliferative disorder Number of… (low certainty).

• Immunosuppressive T‐cell antibody induction for heart transplant recipients 2013 · Cochrane Headline outcomes only
  RR 0.74 [0.14, 3.82]
  5 studies · 606 participants
  Low